Bruker Corporation is a medical devices business based in the US. Bruker shares (BRKR.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $53.81 – an increase of 2.87% over the previous week. Bruker employs 7,230 staff and has a trailing 12-month revenue of around $2 billion.
Since the stock market crash in March caused by coronavirus, Bruker's share price has had significant positive movement.
Its last market close was $53.81, which is 7.86% up on its pre-crash value of $49.58 and 72.58% up on the lowest point reached during the March crash when the shares fell as low as $31.18.
If you had bought $1,000 worth of Bruker shares at the start of February 2020, those shares would have been worth $637.84 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,077.28.
|Latest market close||$53.81|
|52-week range||$30.6984 - $55.87|
|50-day moving average||$51.7344|
|200-day moving average||$44.061|
|Wall St. target price||$51.08|
|Dividend yield||$0.16 (0.3%)|
|Earnings per share (TTM)||$1.012|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-14)||-7.35%|
|1 month (2020-12-22)||0.78%|
|3 months (2020-10-22)||25.83%|
|6 months (2020-07-21)||29.26%|
|1 year (2020-01-21)||2.24%|
|2 years (2019-01-18)||57.65%|
|3 years (2018-01-19)||54.60%|
|5 years (2016-01-21)||147.93%|
Valuing Bruker stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bruker's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bruker's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 54x. In other words, Bruker shares trade at around 54x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Bruker's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.64. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bruker's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Bruker's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $335.7 million (£246 million).
The EBITDA is a measure of a Bruker's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2 billion|
|Operating margin TTM||13.2%|
|Gross profit TTM||$1 billion|
|Return on assets TTM||6.18%|
|Return on equity TTM||17.29%|
|Market capitalisation||$8.3 billion|
TTM: trailing 12 months
There are currently 1.7 million Bruker shares held short by investors – that's known as Bruker's "short interest". This figure is 28.9% down from 2.5 million last month.
There are a few different ways that this level of interest in shorting Bruker shares can be evaluated.
Bruker's "short interest ratio" (SIR) is the quantity of Bruker shares currently shorted divided by the average quantity of Bruker shares traded daily (recently around 547841.06583072). Bruker's SIR currently stands at 3.19. In other words for every 100,000 Bruker shares traded daily on the market, roughly 3190 shares are currently held short.
However Bruker's short interest can also be evaluated against the total number of Bruker shares, or, against the total number of tradable Bruker shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bruker's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Bruker shares in existence, roughly 10 shares are currently held short) or 0.0258% of the tradable shares (for every 100,000 tradable Bruker shares, roughly 26 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Bruker.
Find out more about how you can short Bruker stock.
Dividend payout ratio: 15.69% of net profits
Recently Bruker has paid out, on average, around 15.69% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.3% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Bruker shareholders could enjoy a 0.3% return on their shares, in the form of dividend payments. In Bruker's case, that would currently equate to about $0.16 per share.
While Bruker's payout ratio might seem low, this can signify that Bruker is investing more in its future growth.
Bruker's most recent dividend payout was on 18 December 2020. The latest dividend was paid out to all shareholders who bought their shares by 30 November 2020 (the "ex-dividend date").
Over the last 12 months, Bruker's shares have ranged in value from as little as $30.6984 up to $55.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bruker's is 1.2646. This would suggest that Bruker's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation has collaboration with Inscopix. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.